Table 4 Comparison of maternal clinical and lab findings, Antipyretic use, mode of delivery, and prevalence of confirmed chorioamnionitis
| Â | Comparison -Group (1) Vs. Group (2) | ||||
|---|---|---|---|---|---|
| Â | Total patients N=415 | Group (1) PIT 37.6 to 37.90C N= 203 | Group (2) PIT 380C or more N=212 | Odds ratio (95% CI) | PÂ value |
Maternal tachycardia | 251 (60.5%) | 110(54.2%) | 141 (66.5%) | 0.59 (0.40 to 0.89) | 0.010 |
Fetal tachycardia | 198 (47.7%) | 85(41.9%) | 113(53.3%) | 0.63 (0.43 to 0.93) | 0.020 |
WBC >15 N (%) | 188 (45.3%) | 90(44.3%) | 98(46.2%) | 0.93 (6.23 -1.36) | 0.699 |
CRP>20 N (%) | 213/329 (64.7%) | 97/152 (63.8%) | 116/177 (65.5%) | 0.93 (0.59 to 1.46) | 0.745 |
Positive blood culture(mother)N (%) | 25/208 (12%) | 6/68 (8.8%) | 19/140 (13.6%) | 0.62 (0.23 to 1.62) | 0.323 |
Intrapartum antibiotics at least 2 or more hours before delivery | 233 (56.1%) | 119 (58.6%) | 114 (53.8%) | 1.22 (0.83 to 1.79) | 0.320 |
Received paracetamol for temperature below 380C N (%) | 215/297 (72.4%) | 179/203(88.2 %) | 37/95 (38.9%) | 11.69 (6.46 to 21.15) | <0.001 |
LSCS | 190 (45.8%) | 91 (44.8%) | 99(46.7%) | 0.93 (0.64 to 1.37) | 0.706 |
Instrumental vaginal delivery N (%) | 97 (23.4%) | 49(24.1%) | 48(22.6%) | 1.09 (0.69 to 1.71) | 0.719 |
Positive Placenta culture N (%) | 62/275 (22.5%) | 25/134(18.7%) | 37/141(26.2%) | 0.65 (0.36 to 1.15) | 0.132 |
Positive placental pathology N (%) | 29/45 (64.4%) | 12/20 (60%) | 17/25 (68%) | 0.71 (0.21 to 2.41) | 0.577 |
Confirmed chorioamnionitis (based on placental culture or histopathology) N (%) | 82/288 (28.5%) | 35/138 (25.4%) | 47/140 (31.3%) | 0.75 (0.46 to 1.25) | 0.262 |
Confirmed chorioamnionitis (based on the placental culture of LSCS cases or by histopathology) N (%) | 53/177 (29.9%) | 19/87 (21.8%) | 34/90 (37.8 %) | 0.46 (0.24 to 0.89) | 0.021 |